NEIL3 and cancer: However, analysis of mRNA data regarding 13 human cancers showed that increased somatic mutation rates were associated with significantly reduced expression levels of NEIL1/2 and significantly increased expression levels of NEIL3, suggesting that NEIL3 overexpression instead promotes somatic mutation rates in cancer [62].